Forus vs TailorMed (2026)
Both work the gap between a prescription being written and a patient actually taking the medicine, and they are funded differently. Forus automates the paperwork, generating and submitting the prior authorisation, drafting appeals and routing to pharmacy, free to the prescriber. TailorMed finds the money, identifying financially at risk patients and matching them to assistance programmes, sold to providers and pharmacies. Both are legitimate and they are not substitutes. The question to settle first is who pays for the free one, because a platform that routes prescriptions has an economic relationship somewhere in the chain, and neither vendor publishes what the patient is told about who is contacting them.
- It automates the paperwork path from prescription to pharmacy, generating and submitting authorisations, drafting appeals and finding affordability programmes, at no cost to the prescriber.
- Coverage is stated as any drug, any insurance, any pharmacy, embedded at the point of prescribing.
- It states plainly that protected health information is covered under a business associate agreement, alongside a typed attestation.
- It identifies financially at risk patients across a large network of assistance programmes, which is provider side work aimed at what the patient can pay.
- The buyer is the health system or pharmacy, so the incentive is the patient completing therapy affordably rather than a specific therapy being dispensed.
- Financial navigation reaches across therapies and payers rather than following one prescription.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Forus and TailorMed are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Forus | TailorMed |
|---|---|---|
| Primary category | RCM & Prior Auth AI | Healthcare Administrative Automation |
| Founded | 2022 | 2016 |
| Headquarters | New York, New York, United States | New York, New York, United States |
| Website | forus.com | tailormed.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Forus its top capability grade on AI Centrality and HIPAA and BAA Posture. Set against TailorMed, Forus grades higher on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for TailorMed on any axis it scores. Set against Forus, TailorMed does not grade higher on any scored axis, though the two are level on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Forus or TailorMed?
The AI Health Index grades Forus higher than TailorMed on every axis that separates them, several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. TailorMed does not grade higher on any scored axis.
Where do Forus and TailorMed differ most?
The widest separation the AI Health Index records between Forus and TailorMed is on AI Centrality, where Forus grades A and TailorMed grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Forus and TailorMed grade the same?
The AI Health Index grades Forus and TailorMed the same on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Forus and TailorMed not disclosed?
At the last review, at least one of Forus and TailorMed published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
The funding question is the whole comparison on one side: a platform free to the provider is paid for by someone else, and in medication access that is usually a manufacturer or pharmacy channel, so establish who funds it and what data flows back, because a platform routing prescriptions has an interest in where they land.
Neither vendor publishes what the patient is told at first contact, which matters because a patient often cannot tell whether the person helping them works for their clinic or for a drug company. Neither publishes subgroup performance.